According to a new report published by Allied Market Research, titled, “Global HIV Drugs Market by Medication Class and Region: Global Opportunity Analysis and Industry Forecast, 2020–2027.” The global HIV drugs market accounted for $30.89 billion in 2019, and is expected to reach $36.49 billion by 2027, registering a CAGR of 3.8% from 2020 to 2027.
♦ 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞:
https://www.alliedmarketresearch.com/request-sample/1867
Key Findings of the Study –
- North America accounted for 48.40% market share in 2019, and is expected to maintain this trend over the forecast period.
- On the basis of medication class, the multi-class combination drugs segment is anticipated to grow at a CAGR of 4.1% from 2020 to 2027.
- The Asia-Pacific HIV drugs market is estimated to grow at a CAGR of 4.4% during the forecast period.
Human immunodeficiency virus (HIV) is one of the most serious infectious diseases affecting approximately 39.6 million people worldwide at the end of 2018, according to the Joint United Nations Program on HIV / According to AIDS (UNAIDS). Antiretroviral therapy (ART) is used to treat HIV because it stops the growth of the HIV virus. The main factors driving the growth of the market include the rise in HIV infection worldwide and the increasing number of treatments and diagnostics.
In addition, there is an increase in government initiatives to make people aware of HIV causes, symptoms, treatment options, and the critical role of these treatments in controlling the growth of HIV. Hence, raising awareness through such government initiatives is expected to boost the growth of the HIV drug market. However, strict government regulations for the approval and marketing of anti-HIV drugs and the effects of HIV are hampering the market growth.
♦ 𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/purchase-enquiry/1867
By region, the market is segmented into North America, Europe, Asia-Pacific, and LAMEA. The North American region accounted for 48.40% of the overall HIV drug market in 2019 and is expected to maintain this lead during the forecast period. The growth of the HIV drug market in the region is attributed to improved health care systems, high rates of diagnosis and treatment, public funding for R&D and an increase in treatment options. advanced treatment for the HIV-positive population. However, the Asia-Pacific and LAMEA HIV drug market is expected to grow rapidly, registering a CAGR of 4.4% and 3.6%, respectively, during the forecast period, in ‘due to the increase in the number of people infected with HIV in these areas. improvements in health care facilities and increases in rates of HIV testing and treatment.
Key Market Players –
Major key players that operate in the industry are Boehringer Ingelheim International GmbH, Merck & Co., Inc., GalaxoSmithKline plc. AbbVie, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pfizer Inc., Gilead Sciences, Inc., Johnson & Johnson, and Cipla Limited.
By Region –
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of Asia-Pacific)
♦ 𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐡𝐢𝐬 𝐄𝐱𝐜𝐥𝐮𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/checkout-final/839c877e1c8e031c2f893bc3a0854212
Frequently Asked Questions?
Q1. What is the total market value of global HIV drugs market?
Q2. Which market holds the maximum market share of the global HIV drugs market?
Q3. What will be global HIV drugs market growth in 2030?
Q4. What are the key trends in the global HIV drugs market?
Q5. What are the key growth strategies of global HIV drugs market players? Q6. How the company profile has been selected?
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com